More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
CNBC, News 10, UPI, and Investopedia Look at Medical Marijuana, Inc.’s Role as CBD Innovator

CNBC, News 10, UPI, and Investopedia Look at Medical Marijuana, Inc.’s Role as CBD Innovator

by adminAdrianRamirez | Jan 4, 2019 | Media Coverage

Hemp legalization once again dominated this week’s headlines as media sources report how changes to U.S. hemp policy will affect domestic industries. CBD gift guides, national hemp legalization, and the NFL’s enduring CTE epidemic were just some of the trending topics...
Yahoo Finance Features Medical Marijuana, Inc. as Top 5 Hemp-Derived CBD Company

Yahoo Finance Features Medical Marijuana, Inc. as Top 5 Hemp-Derived CBD Company

by adminAdrianRamirez | Jan 4, 2019 | Press Releases

SAN DIEGO, Jan. 3, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that it has garnered news coverage on the top business and financial news website Yahoo Finance. A Dec. 4, 2018,...
Medical Marijuana, Inc. Subsidiary Kannaway® Recognizes First European Brand Ambassador to Achieve Crown Ambassador Elite Rank

Medical Marijuana, Inc. Subsidiary Kannaway® Recognizes First European Brand Ambassador to Achieve Crown Ambassador Elite Rank

by adminAdrianRamirez | Jan 2, 2019 | Kannaway, Press Releases

SAN DIEGO, Jan. 2, 2019 — Medical Marijuana, Inc. (OTC: MJNA), announced today that its subsidiary Kannaway®, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, is recognizing its first European Brand Ambassador to reach the...
Medical Marijuana, Inc. Celebrates End of 80-Year Ban on Domestic Hemp Crop With Passage of 2018 U.S. Farm Bill

Medical Marijuana, Inc. Celebrates End of 80-Year Ban on Domestic Hemp Crop With Passage of 2018 U.S. Farm Bill

by adminAdrianRamirez | Dec 21, 2018 | Press Releases

SAN DIEGO, Dec. 21, 2018 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, announced today that the company applauds the United States Congress for the passage of The Agricultural Improvement Act...
CNBC Features Medical Marijuana, Inc. as a Top 3 Largest Public CBD Company to Look at With the U.S. Farm Bill Federally Legalizing Hemp

CNBC Features Medical Marijuana, Inc. as a Top 3 Largest Public CBD Company to Look at With the U.S. Farm Bill Federally Legalizing Hemp

by adminAdrianRamirez | Dec 20, 2018 | Press Releases

SAN DIEGO, Dec. 20, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that it has garnered news coverage on the top national financial news network CNBC. A Dec. 12, 2018, video on the 2018...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.